Literature DB >> 9151039

Management strategy and long-term outcome for truncus arteriosus.

C P Brizard1, A Cochrane, C Austin, F Nomura, T R Karl.   

Abstract

OBJECTIVE: Evaluation of a consistent policy of elective repair of truncus arteriosus at 2-3 months of age for the patients who are independent of hospital ward care, and long-term outcome.
METHODS: Retrospective study of 82 patients with truncus arteriosus who underwent total repair at the Victorian Paediatric Cardiac Surgical Unit between 1979 and December 1995. The timing was based on a consistent policy of elective repair at 2-3 months of age for patients who were independent of hospital ward care. Earlier repair was performed when the patients were in uncontrolled congestive heart failure.
RESULTS: Follow-up was complete for all patients with a mean of 76 months (1-183). There were 11 hospital deaths (13.4% CL 9-18.5), and five late deaths, actuarial survival at 80 months was 81% (CL 70-88%) with 39 patients uncensored at that point. For the purpose of this presentation, patients have been grouped according to their age at repair; 1, neonates n = 17 (hospital mortality = 5); 2, infants 1-6 months of age n = 48 (hospital mortality = 4); 3, patients beyond 6 months n = 17 (hospital mortality = 2). This series includes 10 patients with interrupted aortic arch with no mortality, and 10 patients with discontinuous pulmonary artery (hospital mortality = 2). Thirty-seven patients have had 54 conduits replaced to date. Using multiple regression, body weight < 3 kg was the only significant independent risk factor for hospital mortality.
CONCLUSIONS: Our management policy tended to gather patients with risk factors described elsewhere into presentation group 1 and low risk truncus patients into presentation group 2. Deferral of surgery to 2-3 months of age is possible and lowers the surgical risk.

Entities:  

Mesh:

Year:  1997        PMID: 9151039     DOI: 10.1016/s1010-7940(97)01155-x

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  8 in total

1.  Persistent Truncus Arteriosus.

Authors:  Barbara Ferdman; Gautam Singh
Journal:  Curr Treat Options Cardiovasc Med       Date:  2003-10

2.  Survival with congenital heart disease and need for follow up in adult life.

Authors:  C Wren; J J O'Sullivan
Journal:  Heart       Date:  2001-04       Impact factor: 5.994

3.  Prenatal diagnosis of truncus arteriosus using multiplanar display in 4D ultrasonography.

Authors:  Francesca Gotsch; Roberto Romero; Jimmy Espinoza; Juan Pedro Kusanovic; Offer Erez; Sonia Hassan; Lami Yeo
Journal:  J Matern Fetal Neonatal Med       Date:  2010-04

4.  Chromosome 22q11 deletion in patients with truncus arteriosus.

Authors:  D B McElhinney; D A Driscoll; B S Emanuel; E Goldmuntz
Journal:  Pediatr Cardiol       Date:  2003-09-04       Impact factor: 1.655

5.  Chromosome 22q11.2 microdeletion in children with conotruncal heart defects: frequency, associated cardiovascular anomalies, and outcome following cardiac surgery.

Authors:  Lidia Ziolkowska; Wanda Kawalec; Anna Turska-Kmiec; Malgorzata Krajewska-Walasek; Grazyna Brzezinska-Rajszys; Jadwiga Daszkowska; Bogdan Maruszewski; Piotr Burczynski
Journal:  Eur J Pediatr       Date:  2008-01-03       Impact factor: 3.183

6.  Long-term outcomes of repaired and unrepaired truncus arteriosus: 20-year, single-center experience in Thailand.

Authors:  Ekkachai Dangrungroj; Chodchanok Vijarnsorn; Prakul Chanthong; Paweena Chungsomprasong; Supaluck Kanjanauthai; Kritvikrom Durongpisitkul; Jarupim Soongswang; Kriangkrai Tantiwongkosri; Thaworn Subtaweesin; Somchai Sriyoschati
Journal:  PeerJ       Date:  2020-05-12       Impact factor: 2.984

Review 7.  New aspects of anesthetic management in congenital heart disease "common arterial trunk".

Authors:  Mohsen Ziyaeifard; Rasoul Azarfarin; Rasoul Ferasatkish
Journal:  J Res Med Sci       Date:  2014-04       Impact factor: 1.852

8.  Surgical repair for persistent truncus arteriosus in neonates and older children.

Authors:  Rawan M Alamri; Ahmed M Dohain; Amr A Arafat; Ahmed F Elmahrouk; Abdullah H Ghunaim; Ahmed A Elassal; Ahmed A Jamjoom; Osman O Al-Radi
Journal:  J Cardiothorac Surg       Date:  2020-05-11       Impact factor: 1.637

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.